Studies Show that Cannabis Drug is an Anti-viral Drug?

Cannabis Drug as an Anti-viral Medicine

Cannabis Drug is an Anti-viral Medicine?

Cannabis Drug is an Anti-viral Medicine?

The active ingredient of cannabis drug or cannabis, delta-9-tetrahydrocannibol (THC), will forestall the replication and activation of many styles of herpes famed to cause cancer, in keeping with a commentary printed these days in BMC drugs. This finding could lead on the thanks to the creation of anti-viral medicine supported non-psychoactive derivatives of THC.

The gamma herpes viruses, Kaposi’s sarcoma Associated animal virus and herpes virus (which causes organ fever), incline infected people to cancer~ like Kaposi’s sarcoma, Burkitt’s cancer, and lymphoma. Kaposi’s sarcoma is especially rife in AIDS sufferers, and is currently the foremost common variety of cancer in continent.

Once infected, it’s virtually not possible to induce obviate the viruses, as they’ll lie dormant for long periods at intervals humour cells (a kind of white vegetative cell of crucial importance to the immune system). The dormant viruses may also activate, explosive out of cells, spreading between look people and inflicting the symptoms of illness.

 

 

 

Degree Immune Suppressant Drug

Delta-9-tetrahydrocannibol (THC)

Dr. Peter Medveczky and his colleagues from University of South Sunshine State found that this reactivation was prevented if infected cells were adult within the presence of THC. additionally, although cultivated cells that ar infected with a mouse gamma herpes die because the virus reactivates, the cells will survive if they’re cultivated in conjunction with THC – any proof that THC prevents infectious agent reactivation.

The researchers showed that THC acts specifically on gamma herpes viruses, because the chemical was unable to stop the reactivation of another connected virus, herpes simplex-1, that causes cold sores.

Previous analysis has shown THC to be a less attackable and selective medication against gamma herpes viruses than the usually used Zovirax, gancicyclovir and foscarnet. Dr. Medveczky believes that THC has its repressing impact by directly or indirectly targeting a infectious agent factor shared by gamma herpes viruses, referred to as ORF50. By preventing activation of this factor, THC will forestall the replication of the virus that this factor controls.

 

“We believe that studies on cannabinoids and herpes viruses are important to continue because there are obvious benefits,” write the authors. “Better understanding may lead to the development of specific non-psychoactive drugs that may inhibit reactivation of cancer-causing herpes viruses.”

 

 

Degree Immune Suppressant Drug

However, Dr. Medveczky additionally stresses that consciousness-altering drug such as cannabis drug will act as associate degree immune suppressant drug. thus intake of cannabis drug or smoking marijuana may cause a lot of hurt than smart to patients infected with these viruses, UN agency typically have weakened immune systems already.

Whether consciousness-altering drug would be preponderantly helpful will solely be tested in experimental animals (e.g. mice infected with the murine gamma herpesvirus). “We haven’t evaluated the result of consciousness-altering drug in associate degree animal model however,” he said. “Therefore, our findings don’t advocate that folks take pot to forestall or treat cancers related to gamma herpes viruses.”

 

TALK TO US

Your Name (required)

Your Email (required)

Subject

Your Message

How to Kill Cancer Cells by Using Cannabis Oil?

Does Cannabis Oil Keep Cancer Cells Alive?

Does Cannabis Oil keeps cancer cells alive?

Does Cannabis Oil keeps cancer cells alive?

Researchers working in the UK have uncovered that cannabis oil can possibly devastate leukemia cells.

Cannabis oil and retinoic corrosive are two strong common cures for bosom disease that are indicating incredible guarantee concerning beating this feared illness.

Utilization of cannabis oil as a remedial operators keeps on being dubious because of its psychoactive symptoms and ensuing lawful status, notwithstanding, pioneer of the group, Dr Wai Man Liu, clarifies: “It is vital to stretch that these cannabis-like substances are far expelled from the cannabis that is smoked. These novel mixes have been particularly intended to be free of the psychoactive elements, whilst keeping up hostile to growth activity.

Scientists have found that cannabidiol (CBD) found in the cannabis plant can ‘switch off’ the quality in charge of metastasis in a forceful type of bosom malignancy called ‘triple negative.”

This structure, which influences 15% of patients, doesn’t have three hormone receptors that the best treatments target. Cells from this malignancy have large amounts of ID-1. At the point when researchers uncovered cells from this malignancy to cannabidiol they were stunned to discover the cells came back to a sound ordinary state. They found that the compound had killed the over-articulation of ID-1, preventing them from making a trip to removed tissues.

Other conceivably treatable tumors that react well to cannabis oil concentrate are types of leukemia, lung, ovarian and mind growths, which additionally have abnormal amounts of ID-1. Research into different types of growth show comparative results.

 

The cannabis oil is greatly strong

The cannabis oil itself is basic. Anybody with a basin, a heap of pot, and a dissolvable can make it. Initially formulated by Canadian cannabis pioneer Rick Simpson — from which it infers one of its names, Simpson oil — the oil is simply cannabis refined to its fundamental dynamic cannabinoids, with however much of the plant material as could reasonably be expected evacuated utilizing the dissolvable. Aldrich’s suppliers of what they call “milagro oil” or miracle oil at Wo/Men’s Alliance for Medical Marijuana in Santa Cruz use Everclear; Finley utilizes 99 isopropryl liquor.

The cannabis oil likewise is greatly strong. Finley says her blend is 72 percent tetrahydracannabinol, or THC, the psychoactive fixing in weed that gets you stoned, and which in lab studies has contracted tumors in rats; and 11 percent cannabidiol, or CBD, the cannabinoid in pot that studies recommend doesn’t get you high yet has mitigating and hostile to tension properties.

It may not be for everybody: Patients begin with a measurements as little as a grain of rice before inclining up to a full gram for each day, a hit that can abandon a few individuals woozy and discombobulated — uncomfortably high. Also, its costly. A pound of good bud runs $2,500 to $3,000 in the Bay Area, and Finley conveys to anyplace in California. Aldrich says a three-month regimen cost her $1,200 a month; Finley charges $5,500 for a two-month

 

Survival Stories of Cancer by intake of Cannabis Oil

Survival Stories of Cancer by intake of Cannabis Oil

 

Survival Stories of Cancer by intake of Cannabis Oil

Lung cancer is an executioner, with almost 70 percent of new cases bringing about passings, as per measurements distributed by the National Cancer Institute. “I thought I was going to bite the dust,” Aldrich says from her Marina District condo. In any case, she didn’t. Also, now, she is caught up with telling any individual who will listen that, alongside eating routine and chemotherapy, an invention of exceedingly thought cannabis oil disposed of her growth in under four months.

These survival stories are turning out to be more normal. A standout amongst the most prominent was the situation of Montana little child Cash Hyde, determined to have a cerebrum tumor at 20 months, whose family credits cannabis oil for keeping the tumor under control and keeping him alive — until a change in Montana state law remove his intake to cannabis oil for a couple of months. The tumor returned and he kicked the bucket in November, at age four.

 

TALK TO US

Your Name (required)

Your Email (required)

Subject

Your Message

Is Cannabis The Solution to Treat Brain Damage From Alcoholism?

Other edges of Cannabis Compounds - Treat Brain Damage

Other edges of Cannabis Compounds – Treat Brain Damage

Cannabis as the key to treat Brain Damage from Alcoholism

Science has repeatedly demonstrated incontestable proof of the extremely low levels of risk, many of us that oppose cannabis use cling firmly to tarnished and dated anti-marijuana arguments.

Excessive alcohol consumption takes a toll on your health in many varied ways and poses a significantly higher risk to health including health ailments in conjunction with malady, disorder, cancer, and even brain damage. However a recent study from the colleges of Maryland and State indicates a unique potential treatment for avoiding and even reversing such brain harm caused by alcohol with the use of cannabidiol.
Cannabidiol (CBD) is a compound found in marijuana. It does not contain any psychoactive constituents, that implies it doesn’t get you high, however it’s connected to varied health benefits.

 

Relapsing nature of alcoholism

Published at intervals the journal medicine chemistry and behavior, the study initial tested harm to the brain caused by alcohol, indicating neuro-degeneration, and activity and psychological feature impairments. This harm is believed to play employment at intervals the chronic “relapsing nature of alcoholism”. The researchers administered covering cannabidiol in laboratory rats. each employing a needle injection methodology and a pad methodology, the rats strengthen neuroprotection at regarding fifty the troubles. These results justify further designation development of covering CBD for the treatment of alcohol-induced neurodegeneration. it has been prompt that the neuroprotective effects of CBD discovered throughout binge alcohol induced neurodegeneration unit as a results of its high substance capability.

 

“By any of the major criteria of harm – mortality, morbidity, toxicity, addictiveness and relationship with crime – cannabis is less harmful than any of the other major illicit drugs, or than alcohol or tobacco.”
– Report of the British Police Foundation March 2000

 

 

Other edges of Cannabis Compounds for Brain Damage

Other edges of Cannabis Compounds for Brain Damage

Other edges of Cannabis Compounds for Brain Damage

Numerous studies have showcased however CBD and alternative cannabinoids found in marijuana have sturdy inhibitor properties and various health edges. It looks like we have a tendency to uncover fresh and new applications for these compounds nearly monthly. whereas this is often solely the start of watching neuroprotection applications for brains broken by alcohol consumption, alternative edges of cannabis are well documented. A few weeks past, I wrote regarding four important studies linking cannabis and brain cancer treatment. These studies found out that cannabis compounds cannot solely kill cancerous cells within the brain yet conjointly defend healthy cells – one thing ancient cancer treatments cannot do. Research has also connected cannabis with the treatment of depression, indicating its benefits reach from the physical to the mental. But, despite the mounting body of evidence to the contrary, marijuana continues to be vilified by those who treasure the failed War on Drugs. The US government labels cannabis a schedule one narcotic along with heroin and LSD; they also say it has no medicinal value. – all while holding patents on cannabis constituents. Though science has repeatedly demonstrated its health benefits.and limited risks, those who oppose the plant cling steadfastly to flawed and dated anti-marijuana arguments.

 

TALK TO US

Your Name (required)

Your Email (required)

Subject

Your Message

Medicinal Cannabis Authorization Diminishes Painkiller Overdose Deaths

Medicinal Cannabis is Extremely Effective for Pain Relief

A huge joint study (no joke expected) by the Johns Hopkins Bloomberg School of Public Health in Baltimore, the University of Pennsylvania in Philadelphia and the Albert Einstein College of Medicine in New York City was led to focus the effect on decreasing remedy opioid passings in states with therapeutic maryjane.

Would you have speculated that there was up to a 33 percent decrease in opioid overdose deaths among the 13 zones that permit restorative maryjane? The study’s outcomes were distributed late August 2014, shockingly, in the Journal of the American Medical Association (JAMA). Their examination secured the period from 1999 to 2010, as the 13 states, starting with California, started their restorative weed arrangements.

By inspecting state demise endorsements, the specialists found that, after the first year of sanctioning cannabis for restorative purposes, the recommended opioid painkiller overdose deaths declined by 20 percent. Following two years of sanctioned therapeutic maryjane in every state, opioid overdose deaths declined by 25 percent. Following five years, the rate had declined 33 percent.

 

DEA: Another onerous administration office

Medicinal cannabis authorization diminishes painkiller overdose deaths

The DEA (Drug Enforcement Administration) needs to toss everybody behind bars who smokes an amiable joint for unwinding and increased mindfulness or uses any cannabis oil to cure maladies and treat pains that coctail pharmaceuticals have normally exacerbated more than alleviated.

The DEA, under the US Justice Department’s umbrella, the government organization that additionally runs the Bureau of Alcohol, Tobacco, Firearms and Explosives, which supported unlawful firearm rushing to Mexican drug cartels and groups with their clandestine “Quick and Furious” operation, has chosen to keep posting cannabis as a Schedule I medicate.

 

Here is Associate in Nursing excerpt from the official Drug Enforcement Administration site:

Schedule I medicine, substances, or chemicals square measure outlined as medicine with no presently accepted medical use and a high potential for abuse. Schedule I medicine square measure the foremost dangerous medicine of all the drug schedules with probably severe psychological or physical dependence. [Emphasis added]

And simply to allow you a concept of however heavy-handed and glued the Drug Enforcement Administration is on guaranteeing that they get heavily funded to feed the jail system by throwing non-violent pot smokers in jail with the shibboleth “tough work, very important mission” on their website, here’s a real incident with Associate in Nursing ironic twist.

In 1974, the Justice Department’s Drug Enforcement Administration elite the Virginia Medical faculty to receive federal agency (National Institutes of Health) funding to try to to marijuana analysis on research lab rats and prove however marijuana adversely affects the system and brain.

Cannabis Exposed Rats Cures Brain Cancer

The researchers in all probability shocked themselves, as they witnessed cannabis-exposed rats get over brain cancer instead. it had been a surprise that did not please the Drug Enforcement Administration, that ordered the funding stopped and had the medical college’s analysis documents destroyed.

Since then there are many international medical cannabis studies that have resulted in positive results as treatments for brain disease, seizures, pain, non-appetite, nausea, anxiety, PTSD, inflammatory viscus disorders and cancer.

By distinction, medically approved pharmaceutical opioid pain relievers are classified as Schedule II, which incorporates wrongfully prescribed opioids that cause additional drug deaths once medical marijuana isn’t available:

Plan II medications, substances, or chemicals are characterized as medications with a high potential for ill-use, less ill-use potential than Schedule I tranquilizes, with utilization conceivably prompting serious mental or physical reliance. These medications are additionally viewed as perilous. A few samples of Schedule II medications are:

cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin [Emphasis added]

Vicodin is in Schedule III. Note that the expression “no as of now acknowledged therapeutic utilization” is not utilized for Schedule II, III, IV or V, just Schedule I.

Busting down entryways and colliding with threatened homes with “unlawful” weed at 6:00 AM, perhaps executing a family canine or two, is an “intense fundamental mission.” Prescribing perilous Ritalin to youngsters under five is legitimate.

 

TALK TO US

Your Name (required)

Your Email (required)

Subject

Your Message

Cannabidiol inhibits human brain tumor cell migration through a cannabinoid receptor-independent mechanism

We evaluated the flexibility of cannabidiol (CBD) to impair the migration of growth cells stirred by conditioned medium. CBD caused concentration-dependent inhibition of the migration of U87 brain tumour cells, quantified in a very Boyden chamber. Since these cells specific each cannabinoid CB1 and CB2 receptors within the membrane, we have a tendency to additionally evaluated their engagement within the antimigratory impact of CBD. The inhibition of cell wasn’t antagonized either by the selective cannabinoid receptor antagonists SR141716 (CB1) and SR144528 (CB2) or by pretreatment with respiratory disease poison, indicating no involvement of classical cannabinoid receptors and/or receptors coupled to Gi/o proteins. These results reinforce the proof of antitumoral properties of CBD, demonstrating its ability to limit growth invasion, though the mechanism of its pharmacologic effects remains to be processed.

 

Cannabinoids

Cannabinoids, the active elements of cannabis, and their derivatives, have a good spectrum of pharmacologic effects exerted through specific semipermeable membrane G-protein-coupled receptors. 2 cannabinoid receptors, CB1 and CB2, are cloned and characterised from class tissues. Cannabinoids induce the inhibition of adenylate cyclases, influence ionic channels, and stimulate extracellular-signal-regulated enzyme (ERK), c-Jun N-terminal enzyme, and p38 mitogen-activated supermolecule enzyme, indicating that they’ll play a general role within the cell survival or death call.

Numerous recent reports state that cannabinoids inhibit the viability of assorted sorts of cancer cells in vitro and in vivo. Cannabinoids induce necrobiosis of malignant brain tumor cells, that is, from the foremost common primary cerebral neoplasm in adults. However, the hallucinogenic effects of those compounds limit their medicative use.

In a previous work, we have a tendency to incontestable that the nonpsychoactive cannabinoid compound, cannabidiol (CBD), will limit brain tumor cell growth in vitro or in vivo, by inducement programmed death. However, the characteristic diffuse infiltrative growth of gliomas makes surgical removal not possible and well complicates the clinical management of those patients.

In general, neoplasm cell invasion may be a complicated method involving adhesion to molecules of the animate thing matrix, degradation of matrix element, and later active neoplasm cell locomotion (migration). Therefore, associate understanding of the capability of CBD to forestall brain tumor cell migration would be vital and will in all probability improve its use as a possible antitumoral compound.

The cannabinoids have complicated effects on cell migration, stimulating or inhibiting counting on the cell sort studied. very little is thought concerning their action on neoplasm cell motility. Anandamide inhibits the migration of human colon cancer cells (SW480) through a CB1-dependent mechanism. In distinction, 2-AG will increase the migration of HL-60 cells, and murine chronic myelocytic leukemia cells Since CBD’s effects on malignant brain tumor cell migration haven’t been investigated however, we have a tendency to investigated however this compound influences the motility of human brain tumor cells, and additionally thought-about the pharmacologic viewpoint, assessing the role of cannabinoid receptors CB1 and CB2.

 

Effects of cannabinoid receptor antagonists on CBD-induced inhibition of cell migration

Most of the consequences of cannabinoids on the central system represented to date ar believed to be exerted through the cannabinoid receptor. to see whether or not CBD-induced inhibition of cell migration was obsessed on the stimulation of those receptors, 1st we tend to checked the presence of the receptors in our cell lines.

There are results of immunoblot experiments for CB1 and CB2 receptors. one band of roughly 59 kDa mass was obtained for U87 cells, comparable the band determined in murine brain tumor cells C6 and human brain tumor cell line U373 used as positive management, wherever CB1 have already been incontestible. The expression of the cannabinoid receptor CB2 in human brain tumor cells, with a mass of roughly 40 kDa, that is comparable CB2 receptors within the spleen that categorical 2 forms differing in mass probably owing to totally different glycosylated sorts of the receptors.

 

Glioma Cells

Threatening gliomas are exceptionally invading, proliferative tumors. Glioma cells take after a trademark example of development, attacking the adjoining ordinary mind structures and encompassing extensive veins. Restraining relocation is along these lines a fundamental step towards enhancing the visualization of patients with threatening gliomas. In a past study, we showed that CBD, a nonpsychotropic subsidiary of pot, impeded the feasibility of human glioma cell lines U87 and U373 in vitro and in vivo, proposing its potential restorative utilization.

The present study shows, surprisingly, that CBD can hinder the movement of U87 human glioma cells in vitro. The cannabinoids’ consequences for cell relocation have as of now been accounted for, in spite of the fact that the principle studies were on resistant cells or endothelial cells, coming about once in a while in clashing information relying upon the cell sort. Incitement of the CB2 receptor by the endocannabinoid 2-AG was accounted for to expand the relocation of HL60 and mouse microglia. Interestingly, THC or the manufactured agonist CP-55,940 hindered macrophage relocation, including both receptors, CB1 and CB2. Anandamide has likewise been portrayed as having the capacity to repress the movement of SW480 colon carcinoma cells.

Here, we found that CBD created fixation related restraint of glioma cell relocation in a scope of fixations beginning from 0.01 up to 9 μm, which did not influence cell reasonability, as we have officially reported. In a first endeavor to clear up the system of activity of CBD, we examined whether the restraint of tumor cell movement was because of the traditional cannabinoid receptors. Neither the CB1 rival SR141716 nor the CB2 foe SR144528 kept the cell relocation hindrance because of CBD. Likewise, the blend of the two cannabinoid rivals or the TRPV1 receptor rival capsazepine neglected to estrange the inhibitory impacts of CBD, fortify our past information on the antiproliferative impacts of CBD that came about free of cannabinoid and vanilloid receptors.

The part of cannabinoid receptors in CBD’s pharmacological impacts is at any rate disputable. Tying studies have demonstrated to it could tie to cannabinoid receptors, however in our pharmacological study, the particular adversaries did not piece CBD’s belongings in vitro. Since the presence of a third sort of cannabinoid receptor has been recommended to which CBD could possibly tie, with a perspective to barring any collaboration with Gi/o-coupled receptors, we assessed the impact of CBD on cell relocation likewise in the vicinity of PTX which, nonetheless, was not able to avert CBD-instigated restraint, implying that CBD does not act through cannabinoid and/or different receptors coupled to Gi/o proteins. These information are in accordance with our past results about the proapoptotic impact of CBD on human glioma cells, which was not identified with its cooperation with cannabinoid receptors.

Since CBD has been accounted for to invigorate mouse microglia BV-2 cell relocation through potential tying with a still not completely portrayed receptor named ‘endothelial receptor touchy to Ab-CBD, we could estimate that CBD’s impact in glioma may be because of a collaboration with a comparative kind of receptor indicating opposite agonist properties.

Conclusion

All in all, the present study illustrates, interestingly, that CBD can hinder the movement of tumoral cells. Despite the fact that the component of this activity is not clear right now, we can reject any engagement of traditional cannabinoid receptors and/or Gi/o-coupled receptors. Our information further bolster the utilization of cannabinoids as antimetastatic medications as already exhibited for met-fluoro-anandamide on rodent thyroid growth cell. This antimigratory property, together with the known antiproliferative and apoptotic highlights of CBD, reinforce the proof for its utilization as a potential antitumoral operato

 

TALK TO US

Your Name (required)

Your Email (required)

Subject

Your Message